U.S. health agencies are investing in vaccines that are aimed at preventing cancer from returning, officials said March 22.
The Department of Health and Human Services (HHS) and the National Cancer Institute have launched a public-private partnership to pay for clinical trials that will test vaccines developed to generate an immune attack on tumors, the agencies said.





